Insider trades
Diana Brainard, Director of Nektar Therapeutics NKTR, has filed 0 purchases and 31 sales on the open market. The latest trade was on 09/23.
Diana Brainard
Director
- Company
- Nektar Therapeutics NKTR
- First filing
- 23/01/23
- Trades
- 37 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- No record
- Last trade
- 09/23
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 24/11/19 | 24/11/20 | 8,706 sh | $0.55 | $4,788.3 | −1.2% | |
| Open-market sale | 24/11/05 | 24/11/06 | 10,609 sh | $0.86 | $9,123.74 | −1.4% | |
| Open-market sale | 24/10/21 | 24/10/23 | 9,752 sh | $0.78 | $7,606.56 | −1.3% | |
| Open-market sale | 24/10/03 | 24/10/04 | 1,493 sh | $0.81 | $1,209.33 | −0.2% | |
| Open-market sale | 24/08/20 | 24/08/22 | 5,390 sh | $0.74 | $3,988.6 | −0.7% | |
| Open-market sale | 24/08/19 | 24/08/20 | 3,091 sh | $0.76 | $2,349.16 | −0.4% | |
| Open-market sale | 24/08/05 | 24/08/07 | 10,847 sh | $0.73 | $7,918.31 | −1.4% | |
| Open-market sale | 24/07/19 | 24/07/23 | 9,731 sh | $0.75 | $7,298.25 | −1.2% | |
| Open-market sale | 24/07/02 | 24/07/03 | 1,489 sh | $0.72 | $1,072.08 | −0.2% | |
| Open-market sale | 24/05/21 | 24/05/23 | 5,149 sh | $0.79 | $4,067.71 | −0.7% | |
| Open-market sale | 24/05/17 | 24/05/21 | 3,075 sh | $0.75 | $2,306.25 | −0.4% | |
| Open-market sale | 24/05/03 | 24/05/07 | 10,240 sh | $0.80 | $8,192 | −1.3% | |
| Open-market sale | 24/04/19 | 24/04/23 | 9,601 sh | $0.75 | $7,200.75 | −1.2% | |
| Open-market sale | 24/04/02 | 24/04/04 | 1,533 sh | $0.77 | $1,180.41 | −0.2% | |
| Open-market sale | 24/02/20–24/02/21 | 24/02/22 | 8,252 sh2 trades | $0.71avg. | $5,827.95 | −1.0% | |
| Open-market sale | 24/02/05 | 24/02/06 | 41,421 sh | $0.67 | $27,752.07 | −4.8% | |
| Open-market sale | 24/01/23 | 24/01/25 | 9,500 sh | $0.67 | $6,365 | −1.1% | |
| Open-market sale | 24/01/04 | 24/01/08 | 1,664 sh | $0.64 | $1,064.96 | −0.2% | |
| Open-market sale10b5-1 plan | 23/11/17–23/11/20 | 23/11/21 | 7,071 sh2 trades | $1.67avg. | $11,788.65 | −0.8% | |
| Open-market sale10b5-1 plan | 23/10/19 | 23/10/23 | 8,581 sh | $1.58 | $13,557.98 | −1.0% |